Rosette Lidereau

26.9k citations

263 papers · 16.1k indexed · 2 hit papers · h-index 70

Cancer Research top 0.1%
- Cancer Genomics and Diagnostics 41
Oncology top 0.2%
- Cancer-related Molecular Pathways 47
- HER2/EGFR in Cancer Research 24
Molecular Biology top 0.5%
- Genomics and Chromatin Dynamics 27
Genetics top 0.2%
- BRCA gene mutations in cancer 28
- Genomic variations and chromosomal abnormalities 23
- Estrogen and related hormone effects 22
Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 29

Co-authors: Ivan Bièche Robert Callahan Michel Vidaud Sengül Tozlu Sophie Vacher Keltouma Driouch Charles Theillet Igor Girault
Cited by: Cancer Research Oncology Molecular Biology
Journals: International Journal of Cancer (18 papers)Genes Chromosomes and Cancer (11 papers)British Journal of Cancer (11 papers)
Partner nations: France United States Italy

In The Last Decade

Rosette Lidereau

259 papers receiving 15.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Rosette Lidereau

Since Specialization

Citations

This map shows the geographic impact of Rosette Lidereau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosette Lidereau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosette Lidereau more than expected).

Fields of papers citing papers by Rosette Lidereau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosette Lidereau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosette Lidereau. The network helps show where Rosette Lidereau may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rosette Lidereau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rosette Lidereau Line = papers co-authored together Rosette Lidereau links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk Molecular Cancer Research ·Ambre Petitalot,Elodie Dardillac,Eric Jacquet,Y A Al-Abed,Josée Guirouilh‐Barbat,雅巳室,Takashige Momose,Dorine Bonte,Jean Feunteun,สํานักงานพัฒนาระบบข้อมูลข่าวสารสุขภาพแห่งชาติ,Hanif Nur Rokhim,Jean-Christophe Aude,Nitin Hosmelkar,Étienne Rouleau,Rosette Lidereau,Bernard S. López,Sophie Zinn‐Justin,Sandrine M. Caputo	2018	19
2	Expression of ANRIL –Polycomb Complexes– CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene ( EZH2/CBX7 ) Signature with Independent Prognostic Value Molecular Cancer Research ·Didier Meseure,Sophie Vacher,Kinan Drak Alsibai,Nicolás André,Walid Chemlali,Martial Caly,Rosette Lidereau,Éric Pasmant,Céline Callens,Ivan Bièche	2016	82
3	Prediction of BRCA1 Germ-Line Mutation Status in Patients with Breast Cancer Using Histoprognosis Grade, MS110, Lys27H3, Vimentin, and KI67 Pathobiology ·Mohamed Hassanein,Laëtitia Huiart,Violaine Bourdon,강태인,Н.М. Філімоненко,Catherine Noguès,وصفي عبد العزيز,Paul Gesta,Maryam Islam Sayyada,Hélène Dreyfus,Zhou Wang,Rosette Lidereau,Tetsuro Noguchi,François Eisinger,Jean Marc Extra,Patrice Viens,Jocelyne Jacquemier,Hagay Sobol	2013	10
4	Exon-Based Clustering of Murine Breast Tumor Transcriptomes Reveals Alternative Exons Whose Expression Is Associated with Metastasis Cancer Research ·Martin Dutertre,Magali Lacroix‐Triki,Keltouma Driouch,Pierre de la Grange,Lise Gratadou,Samantha Beck,Stefania Millevoi,Jamal Tazi,Rosette Lidereau,Stéphan Vagner,Didier Auboeuf	2010	53
5	Estrogen Regulation and Physiopathologic Significance of Alternative Promoters in Breast Cancer Cancer Research ·Martin Dutertre,Lise Gratadou,Étienne Dardenne,Sophie Germann,Samaan Samaan,Rosette Lidereau,Keltouma Driouch,Pierre de la Grange,Didier Auboeuf	2010	65
6	High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors Cancer Research ·Élodie Manié,Anne Vincent‐Salomon,Jacqueline Lehmann‐Che,Gaëlle Pierron,Elisabeth Turpin,Mathilde Warcoin,Nadège Gruel,Ingrid Lebigot,Xavier Sastre‐Garau,Rosette Lidereau,Audrey Remenieras,Jean Feunteun,Olivier Delattre,Hugues de Thé,Dominique Stoppa‐Lyonnet,Marc‐Henri Stern	2009	112
7	A Six-Gene Signature Predicting Breast Cancer Lung Metastasis Cancer Research ·Alexandra Amherd Hidalgo,Amanda Jackson,Akeila Bellahcène,Nadia Rucci,Soraya Sin,Berta Martín,Àngels Sierra,Alain Boudinet,Jean‐Marc Guinebretière,Enrico Ricevuto,Catherine Noguès,M Briffod,Ivan Bièche,P. Chérel,Teresa García,Vincent Castronovo,Anna Teti,Rosette Lidereau,Keltouma Driouch	2008	121
8	Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer Journal of Molecular Endocrinology ·Sandra E. Ghayad,Julie A. Vendrell,Ivan Bièche,Frédérique Spyratos,Charles Dumontet,Isabelle Treilleux,Rosette Lidereau,Pascale A. Cohen	2008	55
9	mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene expression levels European Journal of Cancer Supplements ·Pascale A. Cohen,Ivan Bièche,Julie A. Vendrell,Céline Keime,Rosette Lidereau,Charles Dumontet,Sandra E. Ghayad	2008	1
10	Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer Cancer Research ·Jeroen T. Buijs,Nico V. Henriquez,Petra G.M. van Overveld,Geertje van der Horst,Ivo Que,Ruth Schwaninger,Cyrill A. Rentsch,Peter ten Dijke,Anne‐Marie Cleton-Jansen,Keltouma Driouch,Rosette Lidereau,Richard Bachelier,Slobodan Vukičević,Philippe Clézardin,Socrates E. Papapoulos,Marco Cecchini,Clemens W.G.M. Löwik,Gabri van der Pluijm	2007	157
11	CXC chemokines located in the 4q21 region are up-regulated in breast cancer Endocrine Related Cancer ·Ivan Bièche,Carine Chavey,Catherine Andrieu,Muriel Busson,Sophie Vacher,Ludovic Le Corre,J M Guinebretière,Zainab Khaled Mohamed,Rosette Lidereau,Gwendal Lazennec	2007	145
12	Real-time RT-PCR: a complementary method to detect HER-2 status in breast carcinoma. PubMed ·Céline Bossard,Ivan Bièche,V Le Doussal,Rosette Lidereau,سميرة حسين حمد	2006	21
13	Molecular Profiling of Inflammatory Breast Cancer Clinical Cancer Research ·Ivan Bièche,Florence Lerebours,Sengül Tozlu,Marc Espié,M. Marty,Rosette Lidereau	2004	188
14	Clinical and Experimental Progression of a New Model of Human Prostate Cancer and Therapeutic Approach American Journal Of Pathology ·Gonzague de Pinieux,Marie‐Emmanuelle Legrier,А С Бородина,Yves Courty,Rui Bras-Gonçalves,Anne‐Marie Dutrillaux,Fariba Némati,Stéphane Oudard,Rosette Lidereau,Pierre Broqua,Jean‐Louis Junien,Bernard Dutrillaux,Marie‐France Poupon	2001	41
15	Fluorescence In Situ Hybridization and Immunohistochemical Assays for HER-2/ neu Status Determination Archives of Pathology & Laboratory Medicine ·Peter Onody,Françoise Bertrand,Françoise Muzeau,Ivan Bièche,Rosette Lidereau	2001	19
16	Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. PubMed ·Ivan Bièche,Béatrice Parfait,Яценко Я.В.,Martine Olivi,Marie‐Christine Rio,Rosette Lidereau,Michel Vidaud	2001	115
17	Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer. PubMed ·Ivan Bièche,Rosette Lidereau	2000	38
18	PTEN/MMAC1/TEP1 involvement in primary prostate cancers Oncogene ·Sandrine Pesche,Alain Latil,Françoise Muzeau,Olivier Cussenot,Georges Fournier,Michel Longy,Charis Eng,Rosette Lidereau	1998	104
19	Génétique somatique du cancer du sein Bulletin du Cancer ·Ivan Bièche,Rosette Lidereau	1997	1
20	Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer. PubMed ·Ivan Bièche,Catherine Tomasetto,Catherine H. Régnier,Christel Moog‐Lutz,Marie‐Christine Rio,Rosette Lidereau	1996	89

About Rosette Lidereau

Rosette Lidereau is a scholar working on Cancer Research, Oncology and Genetics, having authored 263 papers that have together received 16.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (47 papers), Cancer Genomics and Diagnostics (41 papers), Genetic factors in colorectal cancer (29 papers), BRCA gene mutations in cancer (28 papers), Genomics and Chromatin Dynamics (27 papers), HER2/EGFR in Cancer Research (24 papers), Genomic variations and chromosomal abnormalities (23 papers) and Estrogen and related hormone effects (22 papers). The work is most often cited by research in Cancer Research (5.0k citations), Oncology (6.3k citations) and Molecular Biology (9.5k citations). Rosette Lidereau has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Ivan Bièche, Robert Callahan, Michel Vidaud, Sengül Tozlu, Sophie Vacher, Keltouma Driouch, Charles Theillet, Igor Girault, M.H. Champème and Martine Olivi. Their work appears in journals such as International Journal of Cancer, Genes Chromosomes and Cancer, British Journal of Cancer, Oncogene and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact